The FDA raises concerns related to data in Reata’s (RETA) NDA seeking approval for bardoxolone for treating Alport syndrome. An advisory committee meeting is scheduled tomorrow.
Business, Services And Guides For Music Labels
Business, Services And Guides For Music Labels
The FDA raises concerns related to data in Reata’s (RETA) NDA seeking approval for bardoxolone for treating Alport syndrome. An advisory committee meeting is scheduled tomorrow.